In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer

Journal of Biomaterials Applications

Volumn 28, Issue 4, 2013, Pages 580-594

  Chen, Yung Chu ^a   Min, Chia Na ^b   Wu, Han Chung ^c   Lin, Chin Tarng ^b   Hsieh, Wen Yuan ^a  

^a INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

coating material; contrast agents; iron oxide; L peptide; Lipid nanoparticle; nasopharyngeal cancer

Indexed keywords

COATING MATERIAL; CONTRAST AGENT; L-PEPTIDE; LIPID NANOPARTICLES; NASOPHARYNGEAL CANCER;

CELL MEMBRANES; CYTOLOGY; DISEASES; ETHYLENE; IRON OXIDES; MAGNETIC RESONANCE IMAGING; NANOCONJUGATES; NANOPARTICLES; PEPTIDES;

NANOMAGNETICS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CELL SURFACE PROTEIN; FERRIC FERROCYANIDE; IRON; L PEPTIDE; MACROGOL; MAGNETIC LIPID NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PEPTIDE DERIVATIVE; SOLID LIPID NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; EVALUATION; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; NASOPHARYNX CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

COATING MATERIAL; CONTRAST AGENTS; IRON OXIDE; L-PEPTIDE; LIPID NANOPARTICLE; NASOPHARYNGEAL CANCER;

CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NASOPHARYNGEAL NEOPLASMS; PARTICLE SIZE; POWDER DIFFRACTION;

EID: 84886780888     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328212466685     Document Type: Article

References (48)

1. Armstrong RW, Armstrong MJ, Yu CM. Salted fish and inhalants as risk factors in nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res. 1983 ; 43: 2967-2970
2. Ho CK, Lo WCH, Huang PH, et al. Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulfuric acid vapor. Occup Environ Med. 1999 ; 56: 426-428
3. Sievers KW, Greess H, Baum U, et al. Paranasal sinuses and nasopharynx CT and MRI. Eur J Radiol. 2000 ; 33: 185-202
4. Miller FR, Wanamaker JR, Lavertu P, et al. Magnetic resonance imaging and the management of parapharyngeal space tumors. Head Neck. 1996 ; 18: 67-77
5. Carrau RL, Johnson JT, Myers EN. Management of tumors of the parapharyngeal space. Oncology (Huntingt). 1997 ; 11: 633-640
6. Davis W, Harnsberger H, Smoker W, et al. Retropharyngeal space: evaluation of normal anatomy and diseases with CT and MR imaging. Radiology. 1990 ; 174: 59-64
7. Roberts TPL, Chuang N, Roberts HC. Neuroimaging: do we really need new contrast agents for MRI. Radiology. 2000 ; 34: 166-178
8. Yang X, Chen Y, Yuan R, et al. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer. 2008 ; 49: 3477-3485
9. Xiong DA, He ZP, An YL, et al. Temperature-responsive multilayered micelles formed from the complexation of PNIPAM-b-P4VP block-copolymer and PS-b-PAA core-shell micelles. Polymer. 2008 ; 49: 2548-2552
10. Li JB, Shi LQ, An YL, et al. Reverse micelle of star block copolymer as nanoreactor for preparation of gold nanoparticles. Polymer. 2006 ; 47: 8480-8487
11. Liu DH, Zhong CL. Multicompartment micelles formed from star-dendritic triblock copolymers in selective solvents: a dissipative particle dynamics study. Polymer. 2008 ; 49: 1407-1413
12. Huynh DP, Shim WS, Kim JH, et al. PH/temperature sensitive poly(ethylene glycol)-based biodegradable polyester block copolymer hydrogels. Polymer. 2006 ; 47: 7918-7926
13. Xie H, Zhu Y, Jiang W, et al. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials. 2011 ; 32: 495-502
14. Zhang G, Zhang R, Wen X, et al. Micelles based on biodegradable poly(L-glutamic acid)-b-polylactide with paramagnetic Gd ions chelated to the shell layer as a potential nanoscale MRI-visible delivery system. Biomacromolecules. 2008 ; 92: 36-42
15. Jarzyna PA, Gianella A, Skajaa T, et al. Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials. 2009 ; 30: 6947-6954
16. Chen TJ, Cheng TH, Chen CY, et al. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MR. J Biol Inorg Chem. 2009 ; 14: 253-260
17. Hua MY, Liu HL, Yang HW, et al. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas. Biomaterials. 2011 ; 32: 516-527
18. Sun S, Murray CB, Weller D, et al. Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science. 2000 ; 287: 1989-1992
19. Miller MM, Prinz GA, Cheng SF, et al. Magnetic remanent states and quasistatic switching behavior of Fe split-rings for spin field-effect- transistor applications. Appl Phys Lett. 2002 ; 81: 2211-2213
20. Jain TK, Morales MA, Sahoo SK, et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005 ; 2: 194-205
21. Chourpa I, Douziech-Eyrolles L, Ngaboni-Okassa L, et al. Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy. Analyst. 2005 ; 130: 1395-1403
22. Modo M, Bulte JW. Cellular MR imaging. Mol Imaging. 2005 ; 4: 143-164
23. Burtea C, Laurent S, Roch A, et al. C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI. J Inorg Biochem. 2005 ; 99: 1135-1144
24. Boutry S, Laurent S, Elst LV, et al. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Med Mol Imaging. 2006 ; 1: 15-22
25. Babes L, Denizot B, Tanguy G, et al. Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Colloid Interf Sci. 1999 ; 212: 474-482
26. Allemann E, Gurny R, Doelker E. Drug-loaded nanoparticles - preparation methods and drug targeting issues. J Pharmacol Biopharm. 1993 ; 39: 173-191
27. Jones M, Leroux J. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharmacol Biopharm. 1999 ; 48: 101-111
28. Perkins WR, Ahmad I, Li X, et al. Novel therapeutic nano-particles (lipocores): trapping poorly water-soluble compounds. Int J Pharm. 2000 ; 200: 27-39
29. Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev. 2002 ; 54: 235-252
30. Li B, Tom JY, Oare D. Minimization of a polypeptide hormone. Science. 1995 ; 270: 1657-1660
31. Wrighton NC, Farrell FX, Chang R, et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 1996 ; 273: 458-464
32. Young AC, Valadon P, Casadevall A, et al. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J Mol Biol. 1997 ; 274: 622-634
33. Wu HC, Jung MY, Chiu CY, et al. Identification of serotype-specific B-cell epitope of dengue virus type 2 and detection of dengue immunized serum samples by epitope-based peptide antigen. J Gen Virol. 2003 ; 84: 2271-2279
34. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med. 1996 ; 2: 299-305
35. Spear MA, Breakefield XO, Beltzer J, et al. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells. Cancer Gene Ther. 2001 ; 8: 506-511
36. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 1996 ; 380: 364-366
37. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol. 1997 ; 15: 542-546
38. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 1998 ; 279: 377-380
39. Lee TY, Wu HC, Tseng YL, et al. A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery. Cancer Res. 2004 ; 64: 8002-8008
40. Chen YC, Lee WF, Tsai HH, et al. Paclitaxel and iron oxide loaded multifunctional nanoparticles for chemotherapy, fluorescence properties, and magnetic resonance imaging. J Biomed Mater Res - Part A. 2012 ; 100: 1279-1292
41. Lin CT, Wong CI, Chan WY, et al. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest. 1990 ; 62: 713-724
42. Lin CT, Wong CI, Chan WY, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest. 1993 ; 68: 716-727
43. Lin JJ, Chen JS, Huang SJ, et al. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials. 2009 ; 30: 5114-5124
44. Liu X, Hu Q, Fang Z, et al. Magnetic chitosan nanocomposites: a useful recyclable tool for heavy metal ion removal. Langmuir. 2009 ; 25: 3-8
45. Bumb A, Brechbiel M, Brechbiel MW. Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology. 2008 ; 19: 335601-335607
46. Liao Z, Wang H, Lv R, et al. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells. Langmuir. 2011 ; 27: 3100-3105
47. Meyre ME, Raffard G, Franconi JM, et al. Production of magnetic multilamellar liposomes as highly T2-efficient MRI contrast agents. Nanomed: Nanotechnol Biol Med. 2011 ; 7: 18-21
48. Martina MS, Fortin JP, Menager C, et al. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. Am Chem Soc J. 2005 ; 127: 10676-10685